Sector Update: Health Care


Shutterstock photo

Health-care shares were flat to higher in pre-market trade Monday.

In health-care-stocks news, biopharmaceutical company Alexion Pharmaceuticals ( ALXN ) raised its outlook for net product sales and non-GAAP earnings for 2014 to account for increased revenue related to an agreement concluding discussions with the French government regarding the prospective reimbursement of Soliris.

ALXN was up 3.4% in recent pre-market trading , in a 52-week range of $87.01 to $185.43.

Analysts at Oppenheimer downgraded their rating of athenahealth, Inc ( ATHN ) to underperform from perform. The price target on the shares in the business-services company has been set at $140 a share. In pre-market activity, shares of ATHN were down 2.7% to $180.11 with a 52-week range of $82.01 to $206.70.

Also, shares of Regado Biosciences ( RGDO ) jumped more than 41% pre-market Monday, after the biopharmaceutical company said the U.S. Food and Drug Administration has granted its REG1 anticoagulant therapy fast-track development status. The therapy is designed to be used in patients with coronary artery disease during percutaneous coronary interventions.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities
More Headlines for: ALXN , ATHN , RGDO

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by